MariMed Inc. (CSE: MRMD)
Canada
· Delayed Price · Currency is CAD
0.230
0.00 (0.00%)
Sep 25, 2024, 4:00 PM EDT
MariMed Revenue
MariMed had revenue of $40.44M USD in the quarter ending June 30, 2024, with 10.73% growth. This brings the company's revenue in the last twelve months to $156.07M, up 10.97% year-over-year. In the year 2023, MariMed had annual revenue of $148.60M with 10.89% growth.
Revenue (ttm)
$156.07M
Revenue Growth
+10.97%
P/S Ratio
0.39
Revenue / Employee
$216.46K
Employees
721
Market Cap
87.59M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries Inc. | 1.52B |
Trulieve Cannabis Corp. | 1.59B |
Cresco Labs Inc. | 1.01B |
Planet 13 Holdings Inc. | 139.22M |
Ayr Wellness Inc. | 635.84M |
Grown Rogue International Inc. | 28.83M |
Jushi Holdings Inc. | 360.23M |
iAnthus Capital Holdings, Inc. | 229.29M |
MariMed News
- 2 days ago - MariMed Commences Adult-Use Sales at Thrive Wellness Dispensary in Tiffin, Ohio - GlobeNewsWire
- 5 weeks ago - Cannabis Stock Movers For August 22, 2024 - Benzinga
- 5 weeks ago - MariMed Announces Opening of Second Maryland Dispensary - GlobeNewsWire
- 5 weeks ago - Verano, Green Thumb & MariMed's Strong Q2: Unpacking The Cannabis Earnings Surge - Benzinga
- 6 weeks ago - Cannabis Rescheduling Likely 'In The Next 12 Months,' Says MariMed CEO As Company Invests In Key Markets - Benzinga
- 6 weeks ago - Cannabis Rescheduling Likely 'In The Next 12 Months,' Says MariMed CEO As Company Invests In Key Markets - Benzinga
- 6 weeks ago - Cannabis Stock Gainers And Losers From August 12, 2024 - Benzinga
- 7 weeks ago - MariMed Inc. (MRMD) Q2 2024 Earnings Call Transcript - Seeking Alpha